C9orf72 and frontotemporal dementia: The prevalence of ALS and FTD symptomatic overlap is far greater in patients with repeat expansions in the G4C2 promoter of C9orf72 than in patients with sporadic forms ALS; the rate of disease progression in C9orf72 positive patients is also more rapid (Prado et al., 2015).